Lv53
1140 积分 2025-04-24 加入
Reply
22天前
已完结
EGFR/ERBB2 Amplifications and Alterations Associated With Resistance to Lenvatinib in Hepatocellular Carcinoma
29天前
已完结
Circulating tumour DNA for a minimal residual disease assessment and recurrence risk in hepatocellular carcinoma: a systematic review and meta-analysis
1个月前
已完结
Immune checkpoint inhibitors in hepatocellular carcinoma: emerging challenges in clinical practice
1个月前
已完结
Personalized MRD Assessment in Perisurgical ctDNA for Prognostic Prediction in Hepatocellular Carcinoma
1个月前
已完结
Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments
1个月前
已完结
Hepatocellular Carcinoma
1个月前
已完结
Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments
3个月前
已完结
Circulating tumour DNA for a minimal residual disease assessment and recurrence risk in hepatocellular carcinoma: a systematic review and meta-analysis
3个月前
已完结
Divide and conquer: spatially fractionated radiation therapy
4个月前
已完结
皖公网安备34019202002308
